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Objective: We evaluated the 5-year incidence of diabetes in an adult population from 
Greece.
Research design and methods: 3042 individuals (18 years), free of cardiovascular disease, 
participated in the baseline examination (during 2001–2002). Of this sample, 1012 men and 
1035 women were found alive at the time of follow-up, while 32 (2.1%) men and 22 (1.4%) 
women died during this period. The rest were lost to follow-up. Incidence of type 2 diabetes 
mellitus was evaluated in 1806 participants who did not have diabetes at baseline.
Results: The age-adjusted 5-year incidence of diabetes was 5.5% (men, 5.8%; women, 5.2%). 
A linear trend was observed between diabetes incidence and age (5.6% increases in incidence 
per 1-year difference in age, p  0.001). Multiple logistic regression analysis revealed that 
age (OR per 1 yr = 1.04, 95% CI 1.02–1.06), waist (OR per 1 cm = 1.02, 95% CI 1.01–1.003), 
physical activity (OR = 0.62, 95% CI 0.35–1.02) and family history of diabetes (OR = 2.65, 95% 
CI 1.58–4.53), as well as fasting glucose levels (OR per 1 mg/dl = 1.05, 95% CI 1.03–1.07), 
were the most signiﬁ  cant baseline predictors for diabetes, after adjusting for various potential 
confounders. Additionally, presence of metabolic syndrome at baseline evaluation 2.95-fold the 
risk of diabetes (95% CI 1.89–4.61), and showed better classiﬁ  cation ability than the model that 
contained the components of the syndrome (ie, correct classiﬁ  cation rate: 94.5% vs. 92.3%).
Conclusion: Our ﬁ  ndings show that a 5.5% incidence rate of diabetes within a 5-year period, 
which suggests that the prevalence of this disorder in Greece is rising. Aging, heredity, and 
metabolic syndrome were the most signiﬁ  cant determinants of diabetes.
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An international diabetes federation that includes more than 150 countries, estimates 
that the prevalence of type 2 diabetes mellitus is raising persistently and affects about 
6% of people aged 20–79 years; most of them live in developing countries (Mayor 
2006). It is also of interest that the forecasts are at alarming rates, while a considerable 
proportion of diabetic people are unaware of their condition (King et al 1998). Diabe-
tes mellitus is a major contributory cause for heart attacks, blindness, strokes, kidney 
failure and impotence (CDC 2005). Fortunately, there are is convincing evidence from 
randomized clinical trials and prospective epidemiologic studies that those lifestyle 
modiﬁ  cations, including healthy diet, smoking cessation, exercise, and education can 
minimize the burden of the disease (vanDam et al 2002; Panagiotakos et al 2005d; 
Patja et al 2005; Tuomilehto and Wareham 2006).
Despite the clinical importance of diabetes, data about the incidence of the disease 
in developing countries and particularly in low cardiovascular risk populations are lack-
ing. In Greece, results from previous observational studies show that the self-reported Vascular Health and Risk Management 2008:4(3) 692
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diabetes was increased from 2.4% to 3.1%, between 1974 
and 1990 (Katsilambros et al 1993), while the prevalence of 
type 2 diabetes in the ATTICA’s study sample in 2001, was 
7.6% in men and 5.9% in women (Panagiotakos et al 2005a). 
These ﬁ  gures are in accordance with the incidence rates of 
diabetes worldwide. Nevertheless, the incidence of type 2 
diabetes and the signiﬁ  cance of factors affecting the develop-
ment of the disease in the Greek population have never been 
examined. Thus, in this work we sought to examine the 5-year 
incidence of diabetes, in a sample of cardiovascular disease-
free adults from the Attica region, in Greece (ie, the ATTICA 
study; Pitsavos et al 2003), and we have also evaluated the 
effect of several clinical, biological, and lifestyle factors on 
the development of the disease.
Methods
Participants
The ATTICA epidemiological study (Pitsavos et al 2003; 
Panagiotakos et al 2005a) is a health and nutrition survey 
that has been carried out in the province of Attica region 
(including 78% urban and 22% rural areas), during 2001–
2002. People with cardiovascular disease or people living 
in institutions were excluded from the sampling. According 
to the study’s design, 4056 inhabitants from the above area 
were randomly selected to enroll; of them, 3042 agreed to 
participate (1514 were men aged 46 ± 13 years and 1528 were 
women aged 45 ± 13 years). All participants interviewed by 
trained personnel (cardiologists, dieticians, and nurses) who 
used a standard questionnaire.
Baseline measurements
The baseline evaluation included: demographic charac-
teristics (age, sex, and years of school as proxy of social 
status), detailed information regarding personal and family 
history of hypertension, hypercholesterolemia, diabetes, 
dietary and other lifestyle habits, such as smoking status, 
and habitual/leisure time physical activity. In particular, the 
evaluation of the nutritional habits was based on a validated 
semi-quantitative food-frequency questionnaire (Katsouy-
anni et al 1997). All participants were asked to report the 
average intake (per week or day) of several food items 
that they consumed (during the last 12 months). Alcohol 
consumption was measured in wine glasses (100 ml) and 
quantiﬁ  ed by ethanol intake (grams per drink). One wine 
glass was considered to have an equivalent of 12% ethanol 
concentration. Composite scores were used to describe 
overall diet, which are necessary for the evaluation of 
epidemiological associations. Thus, a special Mediterranean 
diet score was used (range 0–55), based on the rationale 
of the Mediterranean dietary pyramid (Panagiotakos et al 
2006). Smokers were deﬁ  ned as those who were smoking 
at least one cigarette per day during the past year or had 
recently stopped smoking (during a year); the rest of the 
participants were deﬁ  ned as nonsmokers. For the ascertain-
ment of physical activity status the International Physical 
Activity Questionnaire was used (IPAQ 2006), as an index 
of weekly energy expenditure using frequency (times per 
week), duration (in minutes per time), and intensity of sports 
or other habits related to physical activity (in expended 
calories per time). According to the IPAQ, participants were 
classiﬁ  ed as: (a) minimally active or inactive, (b) moder-
ately active achieving of at least 600 MET-min/week, and 
(c) highly active when achieving a minimum of at least 1500 
MET-minutes/week, or 7 or more days of any combination 
of walking, moderate-intensity or vigorous intensity activity 
achieving a minimum of at least 3000 MET-minutes/week. 
Body mass index was measured as weight (in kilograms) 
divided by standing height (in meters squared). Obesity was 
deﬁ  ned as body mass index 29.9 kg/m2. Waist circumfer-
ence (in cm) was also measured using standard procedures. 
Arterial blood pressure was measured at the end of the 
physical examination with subject in sitting position. All 
participants were at least 30 minutes at rest. Participants 
whose average of three consecutive measurements of 
blood pressure levels were greater or equal to 140 and/or 
90 mmHg or reported that they were under antihypertensive 
medication were classiﬁ  ed as having hypertension. Blood 
samples were collected from the antecubital vein between 
8 to 10 AM, in a sitting position after 12 hours of fasting and 
alcohol abstinence. Total-, high-density lipoprotein (HDL), 
cholesterols, blood glucose, and triglycerides were also 
measured in all participants, using colorimetric enzymic 
method in a Technicon automatic analyzer RA-1000 (Date-
Behring Marburg GmbH, Marburg, Germany). Low-density 
lipoprotein-cholesterol was calculated using the Friedwald 
method. The intra and inter-assay coefﬁ  cients of variation 
of cholesterol levels did not exceed 4%, triglycerides 4%, 
and glucose 4%. Hypercholesterolemia was deﬁ  ned as 
total cholesterol levels greater than 200 mg/dl or the use of 
lipid-lowering agents. High-sensitivity C-reactive protein 
levels (as markers of low-grade systemic inﬂ  ammation) 
were assayed by particle-enhanced immunonephelometry 
(N Latex; Dade-Behring Marburg GmbH) with a range from 
0.175 to 1100 mg/dl and 0.75 to 1000 mg/dl, respectively. 
The intra-assay and inter-assay coefﬁ  cient of variation 
was 5%.Vascular Health and Risk Management 2008:4(3) 693
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Follow-up
From June to August 2006, the ATTICA study investigators 
performed the 5-year follow-up. Of the 3042 individuals that 
participated in the baseline examination, 1012 men and 1035 
women were found alive at the time of the follow-up, while 
32 (2.1%) men and 22 (1.4%) women died (cardiovascular 
disease [32], cancer [14], and other causes [8]) during the 
5-year period (69% follow-up participation rate). Of the 
participants that did not participate in the re-examination, 
25% were not found because of missing or wrong addresses 
and telephone numbers and 5% declined to be re-examined. 
No signiﬁ  cant differences were observed between those who 
were lost to follow-up and the rest of the participants regard-
ing sex (p = 0.99), age (p = 0.78), education level in years 
of school (p = 0.67), presence of hypertension (p = 0.12), 
diabetes (p = 0.27), and hypercholesterolemia (p = 0.12). 
The re-examination was based on telephone interviews 
(80% of the participants) and on face-to-face interviews 
when telephone number was not available. No differences 
were observed between those contacted by telephone and 
those participated in the face-to-face interviews, regarding 
age (p = 0.77), sex (p = 0.89), and place of living (p = 0.98). 
The re-examination included information about: (a) vital 
status (death from any cause), or development of coronary 
heart disease or stroke, (b) development of hypertension, 
hypercholesterolemia and type 2 diabetes (ie, fasting blood 
glucose levels 125 mg/dl or use of antidiabetic medication), 
among people who did not have these disorders at baseline, 
as well as management of these conditions, (c) assessment 
of body weight, and (d) lifestyle habits, including physical 
activity, smoking status, and intake of various foods. For the 
present analysis people who have been deﬁ  ned as diabetic 
at baseline examination were excluded. Thus, taking into 
account those who were lost to follow-up, data from 1806 
participants were analyzed in this work.
Statistical analysis
Continuous variables are presented as mean values ± standard 
deviation. Categorical variables are presented as absolute and 
relative frequencies. Associations between categorical variables 
were tested using the chi-squared test. Comparisons of mean 
values of normally distributed variables between those who 
developed diabetes and the rest of the participants were per-
formed using the Student’s t-test. Since the exact time to event 
(ie, development diabetes) was not known, the relative risks 
of developing the disease during the 5-year follow-up period 
were estimated using the odds ratios and their corresponding 
95% conﬁ  dence intervals through stepwise multiple logistic 
regression analysis. We used 5% as the cut-off for the probability 
of entering a variable in the model and 10% as the cut-off for 
the probability of removing a variable from the model. The 
probabilities were calculated using the Wald test. Interactions 
between sex and other covariates were tested in all steps, and 
when they were signiﬁ  cant, remained in the ﬁ  nal model. Devi-
ance residuals were used to evaluate model’s goodness-of-ﬁ  t 
and –2loglikelihood of the initial and ﬁ  nal model were also 
calculated. All reported p-values are based on two-sided tests 
and compared to a signiﬁ  cance level of 5%. SPSS version 14 
(Statistical Package for Social Sciences, SPSS Inc, Chicago, IL, 
USA) software was used for all the statistical calculations.
Results
During the period 2001–2006, the crude incidence of diabetes 
was 58 per 1000 men and 53 per 1000 women (p = 0.64). 
Therefore, it could be speculated that the annual incidence 
rate is 1.16% in men and 1.06% in women. The men-to-
women incidence rate ratio was approximately 1-to-1, in 
almost all age groups. However, in people between 65–75 
years old men were 1.5-times more likely to develop diabetes 
compared with women of same age, while in older than 75 
years participants, women were 1.56-times more likely to 
develop the disease compared with men (Table 1). As we can 
see in Table 1, a strong linear trend of diabetes incidence was 
observed across all age groups, in both sexes. In particular, it 
was found that the crude risk of diabetes increased by 5.6% 
per 1-year difference in age (95% CI 4%–7.2%).
The distribution of the baseline demographic parameters 
and cardiovascular risk factors levels, into those who were diag-
nosed as diabetic at follow-up and the rest of the participants 
is presented in Table 2. Unadjusted analysis revealed several 
signiﬁ  cant relationships. For example, people who developed 
diabetes were away from the traditional Mediterranean diet 
(ie, lower diet score), were more likely to have hypertension, 
obesity, and hypercholesterolemia at baseline, and had higher 
body mass index and waist circumference. In addition, people 
who developed diabetes were less educated; the incidence of 
diabetes in people with low education (ie, 6 years of school) 
was 11.0%, while the incidence among people with high educa-
tion (ie, 12 years of school) was 3.8% (p  0.001).
Although, several differences were observed between 
those who developed diabetes and those who did not regarding 
their baseline characteristics (Table 2), residual confounding 
may exist. Thus, multi-adjusted analysis was then applied and 
revealed that age, waist circumference, physical inactivity 
and family history of diabetes, were the baseline factors that 
signiﬁ  cantly predicted the development of diabetes (see ﬁ  nal Vascular Health and Risk Management 2008:4(3) 694
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model; Table 3). Speciﬁ  cally, multiple logistic regression 
analysis showed that 1-year difference in baseline age was 
associated with 4% higher risk of developing diabetes during a 
5-year period, 10 cm difference in baseline measurements 
of waist was associated with 22% higher risk of diabetes, 
10 mg/dl increase in baseline blood glucose levels were 
associated with 62% higher risk of diabetes, and presence of 
family history of diabetes increased the risk of developing 
the disease 2.65-fold (Table 3). At this point it should be 
clariﬁ  ed that body mass index was also a signiﬁ  cant predic-
tor of diabetes (OR per 1 kg/m2 = 1.10, 95% CI 1.03–1.17); 
however, since body mass index was strongly correlated with 
waist (r = 0.74, p  0.0001) and in order to avoid co-linearity, 
we decided to keep waist circumference in the model since it 
showed the best explanatory ability among all anthropometric 
measurements (ie, better goodness-of-ﬁ  t of the estimated 
models that also included age, sex, physical activity status 
dietary habits; -2loglikelihood for body mass index, and 
waist circumference were: 455.9 and 406.8, respectively). 
Furthermore, abnormal waist (ie, 102 cm for men and 
88 cm for women) was associated with 1.52-times higher risk 
of diabetes (95% CI 0.88–2.78). No difference in the predic-
tive ability of anthropometric measurements was observed 
between sexes (p for interaction with sex 0.7). Physical 
activity was inversely associated with the development of 
diabetes, since participants that reported engagement in any 
activity were 0.62-times less likely to develop diabetes. Fur-
thermore, stratiﬁ  ed analysis showed that moderate physical 
activity reduced the odds of diabetes by 59% (p = 0.04), while 
vigorous physical activity did not show any signiﬁ  cance 
(OR = 1.29, 95% CI 0.58–2.88). All the aforementioned rela-
tionships were independent from sex, education status, blood 
lipids and C-reactive protein levels, presence and management 
of hypertension and hypercholesterolemia, dietary habits, and 
smoking status, as measured at baseline examination.
Furthermore, the 5-year incidence of diabetes among 
people with the metabolic syndrome was 12.9%, while the 
incidence among people without the syndrome was 3.9% 
(p  0.001). Multi-adjusted data analysis showed that presence 
of the metabolic syndrome at baseline evaluation 2.95-fold the 
risk of diabetes (95% CI 1.89–4.61). Moreover, the model that 
contained the metabolic syndrome had better classiﬁ  cation 
ability than the model that contained the components of the 
syndrome (ie, correct classiﬁ  cation rate: 94.5% vs 92.3%).
Discussion
In this work we presented the results regarding diabetes inci-
dence from the ATTICA epidemiological study that has been 
contacted in a Greek population. The ﬁ  ndings show that the 
incidence of diagnosed type 2 diabetes in our adult sample 
increased between 2001 and 2006 by 5.5%. Particularly, the 
age-adjusted incidence of diabetes was 5.8% in men and 5.2% 
in women, which means that the Greek diabetes population 
increased by 330,000 people during the ﬁ  ve preceding years. 
This increase in diabetes was mainly a result of aging, abnor-
mal anthropometric measurements, and especially high waist 
circumference, glucose levels, family history of diabetes, and 
physical inactivity. However, it should be underlined that 
these ﬁ  gures may reﬂ  ect a true increase in the incidence of 
diabetes, or an increase in the screening for diabetes, or a 
combination of both. However, rates of diabetes most likely 
reﬂ  ect an increase in the true prevalence (ie, diagnosed plus 
undiagnosed), because changes on the trends of undiagnosed 
diabetes over the relatively short period appear unlikely to 
happen (Eliasson et al 2002).
Previous data from Greece suggests that the prevalence 
of the adult population with known diabetes increased from 
250,000 in 1974 (Katsilambros et al 1993) to 800,000 in 
2000s (Gikas et al 2004; Panagiotakos et al 2005d), repre-
senting a 3-fold increase of the Greek diabetic population 
over the last 3 decades. We observed a considerable increase 
in the prevalence of diabetes of about 1% annually. These 
ﬁ  ndings are in accordance with results of other epidemiologic 
studies in North America and the Mediterranean region, 
which suggests that, apart from the increase in the prevalence 
of diabetes, an increased incidence of diabetes also occurred 
during the last 30 years worldwide (Geiss et al 2006; Fox 
et al 2006; Evans et al 2007). For example, the prevalence 
of diabetes in Greece is close to the prevalence in USA 
(ie, 9.6%) (Geiss et al 2006), in Spain (ie, 11%) (Velverde 
Table 1 Five-year incidence of type 2 diabetes mellitus in men 
and women by age group.
Men Women
# People participated in the follow-up 880 926
Age at baseline 5-year incidence 
of diabetes
Men-to-women
ratio
35 y 0.0% 0.4% -
35–45 y 5.6% 4.2% 1.33
45–55 y 6.3% 7.0% 0.90
55–65 y 11.3% 11.8% 0.95
65–75 y 15.8% 10.5% 1.50
75 y 10.8% 16.7% 0.64
Overall 5.8% 5.3% 1.09Vascular Health and Risk Management 2008:4(3) 695
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et al 2006), and in Cyprus (ie, 10.3%) (Loizou et al 2006). 
Moreover, the observed trend is in accordance to the esti-
mated projection of diabetes prevalence reported by Wild and 
colleagues (2004) (ie, a 57% increase from 2000 to 2030). 
We have also observed that the adjusted incidence of diabetes 
increases by 4% per 1 year difference in age or by 48% per 
decade of life. It could be speculated that the higher increase 
of diabetes in elderly may reﬂ  ect the simultaneously higher 
increase in obesity rates and other co-morbidities related to 
diabetes (Dinsmoor 2006). Furthermore, we observed that 
the diabetes incidence was much higher among persons 
with low education (Table 2). This ﬁ  nding is in accord with 
other reports (Kanjilal et al 2006), and may reﬂ  ect the higher 
prevalence of cardiovascular risk factors, especially obesity, 
among people with low socioeconomic status (Panagiotakos 
et al 2005b). This could also be an explanation why the 
education status did not show any signiﬁ  cance in the multi-
adjusted model where several other factors were also taken 
into account (Table 3). Nevertheless, prevention strategies 
against diabetes epidemic need to speciﬁ  cally target persons 
of lower education.
Several studies have shown that diabetes prevalence is 
strongly associated with the presence of obesity (WHO 1997; 
Kahn et al 2006; Yoon et al 2006) and the metabolic syndrome 
(WHO 1997; Ford et al 2002; Panagiotakos et al 2005c). In a 
recent review paper, Kahn and colleagues (2006) suggested 
that among obese individuals adipose tissue releases high 
amounts of nonesteriﬁ  ed fatty acids, glycerol, hormones, pro-
inﬂ  ammatory cytokines, and other factors that are involved 
in the development of insulin resistance and diabetes. Our 
study revealed that the incidence of diabetes was strongly 
associated with all the investigated anthropometric indices and 
waist circumference showed the most signiﬁ  cant association 
with diabetes rates. Abdominal obesity has been associated 
with increased risk of cardiovascular disease and diabetes, 
mainly, through the development of many metabolic disorders 
Table 2 Baseline characteristics of the ATTICA study’s participants according to the 5-year incidence of type 2 diabetes mellitus
Status at 5-year follow–up
Baseline factors: Nondiabetic Diabetic P
(n = 1706) (n = 100)
Age, y 43 ± 11 53 ± 13 0.001
Male sex, % 49% 51% 0.64
Years of school 13 ± 3 10 ± 4 0.001
Smokers, % 42% 31% 0.03
Physically inactive subjects, % 58% 63% 0.33
Mediterranean diet score (0–55) 26 ± 5 23 ± 6 0.001
Ethanol intake, g/day 8.7 ± 12 11.3 ± 18 0.38
Hypertensive subjects, % 28% 45% 0.001
Systolic blood pressure, mmHg 121 ± 18 128 ± 17 0.001
Diastolic blood pressure, mmHg 79 ± 8 84 ± 9 0.02
Hypercholesterolemic subjects, % 39% 55% 0.001
Total cholesterol, mg/dl 193 ± 41 208 ± 42 0.001
HDL-cholesterol, mg/dl 49 ± 13 45 ± 14 0.04
LDL-cholesterol, mg/dl 122 ± 37 135 ± 40 0.002
Triglycerides, mg/dl 111 ± 67 156 ± 70 0.001
Fasting glucose, mg/dl 89 ± 19 97 ± 18 0.001
hs C-reactive protein, mg/l 1.8 ± 2.3 2.5 ± 2.7 0.01
Obese subjects, % 16% 39% 0.001
Body mass index, kg/m2 26 ± 5 29 ± 4 0.001
Waist, cm
Men 96 ± 11 104 ± 12 0.001
Women 82 ± 10 90 ± 11 0.001
Notes: Data are expressed as mean ± SD or relative frequencies.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.Vascular Health and Risk Management 2008:4(3) 696
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characterized by insulin resistance, including hypertension, 
as well as alterations in homeostasis, ﬁ  brinolysis, and inﬂ  am-
mation (WHO 1997; Panagiotakos et al 2005c).
The metabolic syndrome is also a condition, which is known 
that promotes atherosclerosis and increases the risk of cardio-
vascular disease and diabetes (Ford et al 2002; Haffner 2006; 
Grundy 2006). The two major underlying risk factors for the syn-
drome are obesity and insulin resistance. Both factors are known 
that promote the development of type 2 diabetes. In this work, 
we revealed that presence of metabolic syndrome almost 3-fold 
the risk for diabetes in both sexes and independent from other 
risk factors. Moreover, we observed that the metabolic syndrome 
was better predictor of diabetes than the individual components 
of the syndrome, which suggests that the clustering of conditions 
that deﬁ  ne the syndrome is of major importance.
From the early 1980s, several observational studies sug-
gest that mortality or morbidity caused by atherosclerotic dis-
ease was inversely related to the individuals’ physical activity 
status (Kannel 1976; Leon et al 1987; Pekkanen 1987). Even 
a single session of moderate to long-duration exercise can 
reduce blood pressure, glucose, and triglycerides levels, and 
can increase HDL-cholesterol levels. As a consequence, 
physical activity may moderate the levels of the clinical and 
biochemical components of the metabolic syndrome and, 
therefore reduce its prevalence at population level. Through 
this mechanism, physical activity may also reduce the risk for 
developing diabetes. We observed that presence of physical 
activity was associated with 38% lower risk of diabetes, irre-
spective of age, sex, body mass index, blood glucose levels, 
and other potential confounders (Table 3). We have also found 
that the effect of moderate exercise was more signiﬁ  cant 
than the inﬂ  uence of vigorous activities in the prevention of 
diabetes. The NCEP ATP III suggested therapeutic lifestyle 
changes (NCEP 2001) in order to reduce the prevalence of the 
metabolic syndrome and diabetes, underlying the importance 
of low-saturated diet consumption and physical exercise. 
Thus, public health actions that promote physical activity 
and healthy eating should implemented in social programs 
starting from school years.
Finally, it is known that family history of diabetes is 
strongly associated with the development of the disease, 
implying a genetic predisposition (Harrison et al 2003). We 
observed that people who had a ﬁ  rst degree relative with 
type 2 diabetes experience 2.65-times higher risk of diabetes, 
compared with those that did not have history of the disease 
in their family. However, diabetes is a complex condition 
that involves a combination of genetic and environmental 
factors; thus, DNA testing for susceptibility genes is not yet 
warranted. Despite these considerations, Harisson and col-
leagues (2003) suggested that since family history of diabetes 
reﬂ  ects genetic susceptibility in addition to other factors, it 
could be a useful public health tool for disease prevention.
Limitations
This work has some limitations. At ﬁ  rst the baseline evaluation 
was performed once, and may be prone to measurement error. 
Moreover, we have excluded those with coronary heart disease 
at baseline, which are usually on beta-blockers or/and diuretics. 
Thus, the incidence of type 2 diabetes may have been signiﬁ  -
cantly inﬂ  uenced in our sample. Additionally, telephone call 
for the ascertainment of diabetes is valid only when accurate 
medical records exist; thus, individuals that may develop dia-
betes during the 5-year period, but they did not know it, were 
misclassiﬁ  ed in the re-examination (ie, underestimation of the 
actual incidence rates). However, 97% of the participants that 
were found in the follow-up provided accurate medical records, 
and reported that they have checked their blood glucose levels 
at least once during the preceding period. Furthermore, our 
methodology is similar to those of other cross-sectional surveys 
Table 3 Results from multiple logistic regression analysis that 
evaluated sociodemographic, lifestyle, biological, clinical baseline 
characteristics in relation to 5-year incidence of type 2 diabetes 
in the ATTICA study participants
  Odds ratio  95% Conﬁ  dence
   interval
Initial model
Age (per 1 year)  1.04  1.02–1.07
Male vs. females  1.24  0.35–4.37
Years of school (per 1 year)  0.94  0.81–1.10
Smokers vs. nonsmokers  0.84  0.28–2.25
Mediterranean diet score   0.99  0.97–1.07
(per 1 unit)
Ethanol intake (per 1 g/d)  1.002  0.97–1.03
Physically active vs. inactive  0.40  0.12–1.31
Waist circumference (per 1 cm)  1.05  1.01–1.09
Fasting blood glucose   1.09  1.04–1.14
(per 1 mg/dl)
Hypercholesterolemia (y/n)  0.59  0.17–2.05
Hypertension (y/n)  0.42  0.12–1.45
Family history of diabetes (y/n)  3.93  1.30–11.9
hs C-reactive protein (per 1 mg/l)  1.06  1.87–1.28
Final model  
Age (per 1 year)  1.04  1.02–1.07
Waist (per 1 cm)  1.02  1.01–1.03
Physically active vs. inactive  0.62  0.35–1.02
Fasting blood glucose (per 1 mg/dl)  1.05  1.03–1.07
Family history of diabetes (y/n)  2.65  1.58–4.53
Notes: -2 log(likelihood) for the initial model = 470.6 and for the ﬁ  nal model = 475.4 
(p for the differences in -2loglikelihoods = 0.9).Vascular Health and Risk Management 2008:4(3) 697
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and follow-up epidemiological studies in Europe and the US, 
and therefore our results are comparable. Another limitation 
could be the fact that the relative risks were estimated by the 
odds ratios through multiple logistic regression analysis. This 
may overestimate the actual risk. Finally, misreporting of 
alcohol consumption at the baseline evaluation, due to social 
class, can be a potential confounder in the evaluation of alcohol 
intake on the development of diabetes.
Conclusion
Our ﬁ  ndings show that the prevalence of diabetes has risen 
in the Greek population during the past 5 years. Given the 
aging population, these data suggest that the growing burden 
of diabetes will be extremely dynamic over the next years. 
To reverse this trend, a sustained and effective public health 
response is needed to focus on weight loss and increase 
physical activity by promoting lifestyle changes.
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